Delayed
Nyse
|
5-day change
|
1st Jan Change
|
- USD
|
-.--%
|
|
-20.62%
|
-21.22%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,501
|
5,773
|
4,929
|
-
|
Enterprise Value (EV)
1 |
2,655
|
5,773
|
4,929
|
4,929
|
P/E ratio
|
4.79
x
|
-97.9
x
|
8.45
x
|
7.41
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.07
x
|
1.28
x
|
0.94
x
|
0.86
x
|
EV / Revenue
|
1.07
x
|
1.28
x
|
0.94
x
|
0.86
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
3,824,542
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.39
x
|
-
|
1.42
x
|
1.23
x
|
Nbr of stocks (in thousands)
|
125,000
|
125,497
|
126,281
|
-
|
Reference price
2 |
20.01
|
46.00
|
39.03
|
39.03
|
Announcement Date
|
22/02/23
|
21/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,113
|
2,340
|
4,500
|
5,236
|
5,738
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
510
|
-
|
-
|
-
|
-
|
Operating Margin
|
24.14%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
568
|
598
|
-35
|
676
|
824
|
Net income
1 |
476
|
481
|
-58
|
572
|
655
|
Net margin
|
22.53%
|
20.56%
|
-1.29%
|
10.93%
|
11.42%
|
EPS
2 |
-
|
4.180
|
-0.4700
|
4.620
|
5.270
|
Free Cash Flow
|
-
|
654
|
-
|
-
|
-
|
FCF margin
|
-
|
27.95%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
135.97%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/02/20
|
22/02/23
|
21/02/24
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
-
|
623
|
869
|
1,168
|
851
|
1,612
|
1,168
|
1,213
|
1,364
|
1,490
|
1,369
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-176
|
-203
|
163
|
380
|
-375
|
157
|
164.5
|
172.5
|
181.5
|
187
|
Net income
1 |
115
|
-100
|
-195
|
130
|
306
|
-299
|
134
|
141
|
146
|
151
|
-
|
Net margin
|
-
|
-16.05%
|
-22.44%
|
11.13%
|
35.96%
|
-18.55%
|
11.48%
|
11.62%
|
10.7%
|
10.13%
|
-
|
EPS
2 |
0.7600
|
-0.8000
|
-1.560
|
1.040
|
2.450
|
-2.410
|
1.080
|
1.130
|
1.180
|
1.220
|
1.240
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/22
|
22/02/23
|
03/05/23
|
08/08/23
|
07/11/23
|
21/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
154
|
-
|
-
|
-
|
Net Cash position
|
427
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
654
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.6%
|
7.9%
|
-
|
9.55%
|
11.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
1.15%
|
1.18%
|
Assets
1 |
-
|
-
|
-
|
49,739
|
55,508
|
Book Value Per Share
2 |
-
|
14.40
|
-
|
27.50
|
31.70
|
Cash Flow per Share
|
-
|
27.60
|
-
|
-
|
-
|
Capex
|
-
|
32
|
-
|
-
|
-
|
Capex / Sales
|
-
|
1.37%
|
-
|
-
|
-
|
Announcement Date
|
26/02/20
|
22/02/23
|
21/02/24
|
-
|
-
|
Last Close Price
39.03
USD Average target price
43
USD Spread / Average Target +10.17% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.07% | 79.51B | | +6.49% | 50.22B | | +1.35% | 48.11B | | +9.53% | 42.2B | | +6.55% | 39.71B | | +20.13% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -16.34% | 24.71B |
Other Life & Health Insurance
|